Director, High-Throughput Biology

Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the intersection of chemistry, engineering, computation, and biology to discover novel treatments for life‑threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes which enable real time, molecular‑resolution measurements of protein movement in living cells, thereby unlocking otherwise intractable classes of proteins as drug targets.

Position

The Director, High‑Throughput Biology (HTB) is responsible for the strategy, performance, and evolution of Eikon’s high‑throughput screening and discovery platforms. This role leads end‑to‑end high‑throughput screening execution across automated and imaging‑based platform technologies, ensuring delivery of scalable, reproducible, decision‑enabling data that supports portfolio priorities. Operating at the intersection of biology, automation engineering, and computational science, this leader establishes standards for assay robustness, data quality, platform reliability, and technical execution, while building a high‑performing organization capable of advancing discovery programs efficiently and at scale.

About You

You are a strategic and technically grounded leader who brings deep expertise in high‑throughput screening and platform biology, along with the ability to lead across biology, automation, and computational disciplines. You are comfortable operating at both the strategic and technical level, balancing organizational leadership with hands‑on scientific engagement where needed. You bring strong judgment, cross‑functional leadership, and a commitment to building scalable, resilient systems that support high‑quality discovery execution. You are also experienced in developing teams, strengthening technical depth, and creating shared ownership across critical workflows and capabilities.

What You’ll Do

• Set the vision and operating model for HTB, defining strategy, success metrics, and standards that ensure sustainable, reliable, high‑quality screening data delivery across the portfolio.
• Partner cross‑functionally at the assay‑to‑screening interface to align assay readiness, screening feasibility, platform capabilities, and project priorities.
• Lead high‑throughput screening strategy and execution, partnering with HTB scientists and program leadership to drive prioritization, ensure feasibility, and enable data‑driven decisions.
• Optimize team resourcing and representation to support screening design, execution, analysis, and program engagement across scientists and SRAs.
• Lead an integrated platform organization that aligns biology, automation, and data analytics into a cohesive screening engine, including workflows, robotics integration, quality control, reporting, and data practices.
• Build, develop, and retain a high‑performing team through clear accountability, coaching, and development of technical and cross‑functional capability.
• Provide hands‑on technical leadership by shaping assay strategy, screening design, analytical methods, and data or automation tooling where needed.
• Establish scalable practices through documentation, playbooks, and shared ownership of critical workflows and code to strengthen continuity and reduce single‑point dependency.

Qualifications

• PhD in Biological Sciences, Computational Sciences, or a related discipline with 10+ years of experience in high‑throughput or high‑content screening environments.
• Demonstrated expertise with automated screening platforms, including 384‑ and/or 1536‑well formats.
• Experience screening compound libraries larger than 100k.
• Experience advancing drug discovery programs from hit identification through lead optimization.
• Experience with microscopy‑based or imaging‑enabled screening platforms.
• Experience with genetic screens or systems biology approaches.
• Strong expertise in statistical analysis and large‑scale dataset quality control, with proficiency in Python.
• Experience building or contributing to scalable data processing pipelines.
• Proficiency with compound databases, LIMS, and enterprise data systems.
• Proven cross‑functional leadership across biology, chemistry, engineering, and data teams.
• Experience with single‑molecule imaging technology is preferred.
• Experience with novel technologies or assay development for drug discovery is preferred.
• Strong computational science capability and familiarity with machine learning or artificial intelligence applications in phenotypic or multiparametric screening are preferred.
• Demonstrated ability to build hybrid biology and computational teams is preferred.

At Eikon, employee compensation also includes bonus and equity compensation, in addition to several generous benefit programs, including:

• 401k plan with company matching
• Medical (premiums covered by Eikon at 95%), dental and vision insurance (premiums covered by Eikon at 100%)
• Mental health and wellness benefits
• Weeklong summer and winter holiday shutdowns
• Generous paid time off and holiday policies
• Life/AD&D Insurance (premiums covered by Eikon at 100%) and optional supplemental employee‑paid life/AD&D policies
• Enhanced parental leave benefit
• Daily subsidized lunch program when on‑site

The expected salary range for this role is $213,000 to $232,750 depending on skills, competency, and the market demand for your expertise.

Eikon is proud to be an equal opportunity employer and will consider all qualified applicants for employment.

Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self‑identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.

As set forth in Eikon Therapeutics’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law.

Voluntary Self-Identification of Disability

Form CC-305
Page 1 of 1
OMB Control Number
Expires 04/30/2026

Why are you being asked to complete this form?
We are a federal contractor or subcontractor. The law requires us to provide equal employment opportunity to qualified people with disabilities. We have a goal of having at least 7% of our workers as people with disabilities. The law says we must measure our progress towards this goal. To do this, we must ask applicants and employees if they have a disability or have ever had one. People can become disabled, so we need to ask this question at least every five years.

Completing this form is voluntary, and we hope that you will choose to do so. Your answer is confidential. No one who makes hiring decisions will see it. Your decision to complete the form and your answer will not harm you in any way. If you want to learn more about the law or this form, visit the U.S. Department of Labor’s Office of Federal Contract Compliance Programs (OFCCP) website at

How do you know if you have a disability?
A disability is a condition that substantially limits one or more of your “major life activities.” If you have or have ever had such a condition, you are a person with a disability. Disabilities include, but are not limited to:

• Alcohol or other substance use disorder (not currently using drugs illegally)
• Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, HIV/AIDS
• Blind or low vision
• Cancer (past or present)
• Cardiovascular or heart disease
• Celiac disease
• Cerebral palsy
• Deaf or serious difficulty hearing
• Diabetes
• Disfigurement, for example, disfigurement caused by burns, wounds, accidents, or congenital disorders
• Epilepsy or other seizure disorder
• Gastrointestinal disorders, for example, Crohn’s Disease, irritable bowel syndrome
• Intellectual or developmental disability
• Mental health conditions, for example, depression, bipolar disorder, anxiety disorder, schizophrenia, PTSD
• Missing limbs or partially missing limbs
• Mobility impairment, benefiting from the use of a wheelchair, scooter, walker, leg brace(s) and/or other supports
• Nervous system condition, for example, migraine headaches, Parkinson’s disease, multiple sclerosis (MS)
• Neurodivergence, for example, attention‑deficit/hyperactivity disorder (ADHD), autism spectrum disorder, dyslexia, dyspraxia, other learning disabilities
• Partial or complete paralysis (any cause)
• Pulmonary or respiratory conditions, for example, tuberculosis, asthma, emphysema
• Short stature (dwarfism)
• Traumatic brain injury

Public burden statement: According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.